Agios Pharmaceuticals | Spese Operative

Prezzo Delle Azioni
26.53
Cambio Giornaliero
-0.04 -0.15%
Mensile
-7.04%
Annuale
-20.71%
Q1 Previsione
25.72




Spese Operative Cambiamento Data
AbbVie USD 10.81B 13.45B 2025-12
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amgen USD 5.9B 773M 2025-12
Arrowhead Research USD 223.22M 10.86M 2025-12
Astellas Pharma JPY 436.66B 16.75B 2025-12
AstraZeneca USD 16.69B 5.74B 2025-09
Bayer EUR 10.2B 523M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Exelixis USD 341.4M 13.29M 2025-09
Gilead Sciences USD 4.26B 95M 2025-09
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Incyte USD 4.65B 3.75B 2025-09
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Merck USD 10.16B 558M 2025-12
Moderna USD 1.28B 232M 2025-09
Novartis USD 9.86B 115M 2025-09
Novartis USD 9.77B 401M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09


Agios Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.